Delirious mania: Detection, diagnosis, and clinical management in the acute setting

Journal of Psychiatric Practice

Volumn 19, Issue 1, 2013, Pages 15-28

  Jacobowski, Natalie L ^a   Heckers, Stephan ^a   Bobo, William V ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bell's mania; catatonia; delirious mania; diagnosis; electroconvulsive therapy; lorazepam; management; treatment

Indexed keywords

ADALIMUMAB; ATENOLOL; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; ESMOLOL; LABETALOL; LEFLUNOMIDE; LISINOPRIL; LORAZEPAM; MOOD STABILIZER; OLANZAPINE; PROPOFOL; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; AUDITORY HALLUCINATION; BEDTIME DOSAGE; BIPOLAR I DISORDER; BRAIN CANCER; BRAIN INJURY; CASE REPORT; CATALEPSY; CATATONIA; COGNITIVE DEFECT; DELIRIOUS MANIA; DELIRIUM; DELUSION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISORIENTATION; DRUG DOSE TITRATION; DRUG MEGADOSE; EARLY DIAGNOSIS; ELECTROCONVULSIVE THERAPY; ENCEPHALITIS; EPILEPSY; FECES INCONTINENCE; FEMALE; HALLUCINATION; HUMAN; HYPERACTIVITY; HYPERTENSION; HYPERTHERMIA; IMPULSIVENESS; INSOMNIA; INTOXICATION; IRRITABILITY; MAJOR DEPRESSION; MANIA; MENTAL INSTABILITY; MINI MENTAL STATE EXAMINATION; MUSCLE RIGIDITY; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; PARANOIA; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SEIZURE; SEXUAL BEHAVIOR; STUPOR; URINE INCONTINENCE;

BIPOLAR DISORDER; CATATONIA; DELIRIUM; ELECTROCONVULSIVE THERAPY; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 84873807126     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000426324.67322.06     Document Type: Article

References (84)

1. Fink M. Delirious mania. Bipolar Disord 1999;1:54-60
2. Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci 2001;251:I8-13
3. Calmeil LF. Dictionnaire de medicine; our repertoire general des sciences medicales considerees sous le rapport theorique et pratique. 2nd ed. Paris, France: Bechet; 1832
4. Bell L. On a form of disease resembling some advanced stage of mania and fever. Am J Insanity 1849;6:97-127
5. Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh, UK: E & S Livingstone; 1921
6. Slater E, Roth M. Meyer-Gross clinical psychiatry, third edition. Baltimore, MD: Williams & Wilkins; 1969
7. Mann SC, Caroff SN, Bleier HR, et al. Lethal catatonia. Am J Psychiatry 1986;143:1374-81
8. Taylor MA, Fink M. Catatonia in psychiatric classification: A home of its own. Am J Psychiatry 2003;160:1233-41
9. Carlson GA, Goodwin FK. The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry 1973;28:221-8
10. Ritchie J, Steiner W, Abrahamowicz M. Incidence of and risk factors for delirium among psychiatric inpatients. Psychiatr Serv 1996;47:727-30
11. Friedman RS, Mufson MJ, Eisenberg TD, et al. Medically and psychiatrically ill: The challenge of delirious mania. Harv Rev Psychiatry 2003;11:91-8
12. Mesulam MM. Cholinergic pathways and the ascending reticular activating system of the human brain. Ann N Y Acad Sci 1995;757:169-79
13. Bhat R, Rockwood K. Delirium as a disorder of consciousness. J Neurol Neurosurg Psychiatry 2007;78:1167-70
14. Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord 1999;10:342-4
15. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000;5:132-48
16. Lester DB, Rogers TD, Blaha CD. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 2010;16:137-62
17. Maldonado Jr. Pathoetiological model of delirium: A comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin 2008;24:789-856, ix
18. van der Mast RC, Fekkes D. Serotonin and amino acids: Partners in delirium pathophysiology? Semin Clin Neuropsychiatry 2000;5:125-31
19. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13
20. Berk M, Dodd S, Kauer-Sant'Anna M, et al. Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007; 434:41-9
21. Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 1998;59:11-4
22. Roggenbach J, Muller-Oerlinghausen B, Franke L. Suicidality, impulsivity and aggression - is there a link to 5HIAA concentration in the cerebrospinal fluid? Psychiatry Res 2002;113:193-206
23. Giglio LM, Magalhaes PV, Kapczinski NS, et al. Functional impact of biological rhythm disturbance in bipolar disorder. J Psychiatr Res 2010;44:220-3
24. Arts B, Jabben N, Krabbendam L, et al. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008;38:771-85
25. Robinson LJ, Thompson JM, Gallagher P, et al. A metaanalysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006;93:105-15
26. Daniels J. Catatonia: Clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci 2009;21: 371-80
27. Dhossche DM, Stoppelbein L, Rout UK. Etiopathogenesis of catatonia: Generalizations and working hypotheses. J ECT 2010;26:253-8
28. Northoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: Investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry 1999;67: 445-50
29. Northoff G. Catatonia and neuroleptic malignant syndrome: Psychopathology and pathophysiology. J Neural Transm 2002;109:1453-67
30. Bond TC. Recognition of acute delirious mania. Arch Gen Psychiatry 1980;37:553-4
31. Karmacharya R, England ML, Ongur D. Delirious mania: Clinical features and treatment response. J Affect Disord 2008;109:312-6
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Associ - ation; 2000
33. Stoudemire A. The differential diagnosis of catatonic states. Psychosomatics 1982;23:245-52
34. Duggal HS, Singh I. Drug-induced catatonia. Drugs Today (Barc) 2005;41:599-607
35. Detweiler MB, Mehra A, Rowell T, et al. Delirious mania and malignant catatonia: A report of 3 cases and review. Psychiatr Q 2009;80:23-40
36. Bobo WV, Murphy MJ, Heckers SH. Recurring episodes of Bell's mania after cerebrovascular accident. Psycho - somatics 2009;50:285-8
37. Keck PE Jr, Pope HG Jr, Cohen BM, et al. Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry 1989;46:914-8
38. Danivas V, Behere RV, Varambally S, et al. Electro - convulsive therapy in the treatment of delirious mania: A report of 2 patients. J ECT 2010;26:278-9
39. Hirose S, Horie T. Effectiveness of ECT against delirium during an episode of bipolar disorder: A case report. J ECT 2000;16:316-7
40. Stromgren LS. ECT in acute delirium and related clinical states. Convuls Ther 1997;13:10-7
41. Carroll BT, Anfinson TJ, Kennedy JC, et al. Catatonic disorder due to general medical conditions. J Neuro - psychiatry Clin Neurosci 1994;6:122-33
42. Marsh CM. Psychiatric presentations of medical illness. Psychiatr Clin North Am 1997;20:181-204
43. Cummings JL. Clinical neuropsychiatry. Needham Heights, MA: Allyn and Bacon; 1985
44. Rosebush PI, Mazurek MF. Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol 1996;16: 315-9
45. Glover SG, Escalona R, Bishop J, et al. Catatonia associated with lorazepam withdrawal. Psychosomatics 1997;38: 148-50
46. Bush G, Fink M, Petrides G, et al. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-36
47. Braunig P, Kruger S, Shugar G, et al. The catatonia rating scale I - development, reliability, and use. Compr Psychiatry 2000;41:147-58
48. Northoff G, Koch A, Wenke J, et al. Catatonia as a psychomotor syndrome: A rating scale and extrapyramidal motor symptoms. Mov Disord 1999;14:404-16
49. Lund CE, Mortimer AM, Rogers D, et al. Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. Br J Psychiatry 1991; 158:323-6
50. Peralta V, Cuesta MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res 2001;47:117-26
51. Brown SD, Melton TC. Trends in bioanalytical methods for the determination and quantification of club drugs: 2000-2010. Biomed Chromatogr 2011;25:300-21
52. Ramo DE, Grov C, Delucchi K, et al. Typology of club drug use among young adults recruited using time-space sampling. Drug Alcohol Depend 2010;107:119-27
53. Bobo WV, Fulton RB. Commentary on: Severe manifestations of coricidin intoxication. Am J Emerg Med 2004; 22:624-5
54. Penn HJ, Langman LJ, Unold D, et al. Detection of synthetic cannabinoids in herbal incense products. Clin Biochem 2011;44:1163-5
55. Oulis P, Lykouras L, Gournellis R, et al. Psychomotor disturbances in psychiatric inpatients: A clinical study. Acta Psychiatr Belg 1997;97:181-91
56. Carroll BT. Kahlbaum's catatonia revisited. Psychiatry Clin Neurosci 2001;55:431-6
57. Klerman GL. The spectrum of mania. Compr Psychiatry 1981;22:11-20
58. Rosebush PI, Hildebrand AM, Furlong BG, et al. Catatonic syndrome in a general psychiatric inpatient population: Frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-62
59. Taylor MA. Catatonia. A review of the behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:48-72
60. Fink M, Taylor MA. The catatonia syndrome: Forgotten but not gone. Arch Gen Psychiatry 2009;66:1173-7
61. Philbrick KL, Rummans TA. Malignant catatonia. J Neuro psychiatry Clin Neurosci 1994;6:1-13
62. Gross AF, Smith FA, Stern TA. Dread complications of catatonia: A case discussion and review of the literature. Prim Care Companion J Clin Psychiatry 2008;10:153-5
63. Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:213-35
64. Rosebush PI, Hildebrand AM, Mazurek MF. The treatment of catatonia: Benzodiazepines or ECT? Am J Psychiatry 1992;149:1279-80
65. Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989;50: 18-25
66. Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: Implications for diagnosis and treatment. Clin Neuropharmacol 2005;28: 205-14
67. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: Review and analysis of 115 cases. Biol Psychiatry 1987;22:1004-20
68. Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 1986;143:1587-90
69. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45
70. Arora B, Kannikeswaran N. The serotonin syndrome - The need for physician's awareness. Int J Emerg Med 2010; 3:373-7
71. White DA, Robins AH. Catatonia: Harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991;158: 419-21
72. Shalev A, Munitz H. The neuroleptic malignant syndrome: Agent and host interaction. Acta Psychiatr Scand 1986; 73:337-47
73. Berardi D, Amore M, Keck PE, Jr., et al. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study. Biol Psychiatry 1998;44: 748-54
74. Hawkins JM, Archer KJ, Strakowski SM, et al. Somatic treatment of catatonia. Int J Psychiatry Med 1995;25: 345-69
75. Clothier JL, Pazzaglia P, Freeman TW. Evaluation and treatment of catatonia. Am J Psychiatry 1989;146:553-4
76. Fink M, Taylor MA. Management of catatonia today. In: Fink M, Taylor MA. Catatonia: A clinician's guide to diagnosis and treatment. New York: Cambridge University Press; 2003:147-76
77. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999;156:1-20 American Psychiatric Association
78. American Psychiatric Association, Coffey CE, Weiner RD. The practice of electroconvulsive therapy: Recommen - dations for treatment, training, and privileging, second edition. Washington, DC: American Psychiatric Associ - ation; 2001
79. Wagner KJ, Mollenberg O, Rentrop M, et al. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs 2005;19:745-58
80. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995;81:596-602
81. Saffer S, Berk M. Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone. J ECT 1998;14:89-93
82. Krystal AD, Weiner RD, Dean MD, et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuro - psychiatry Clin Neurosci 2003;15:27-34
83. Loo C, Simpson B, MacPherson R. Augmentation strategies in electroconvulsive therapy. J ECT 2010;26:202-7
84. Van Den Eede F, Van Hecke J, Van Dalfsen A, et al. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005;20:422-9